Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-24-008881
Filing Date
2024-12-31
Accepted
2024-12-31 17:10:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 11979
  Complete submission text file 0001959173-24-008881.txt   13713
Mailing Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005
Business Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005 (346) 355-4099
Alaunos Therapeutics, Inc. (Subject) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-33038 | Film No.: 241593708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE FIRST AVENUE, PARRIS BUILDING 34 NAVY YARD PLAZA BOSTON MA 02129
Business Address
Vieser Jaime (Reporting) CIK: 0001846045 (see all company filings)

Type: 144